You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ALNY Sale Disclosure
Pyott David E I · SEC Form 4 · Filed Jun 3, 2026
Sale
Calculated transaction value
$351.22K
Pyott David E I Director
ALNY
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
ALNY daily price context
Close on/before transaction
$295.63
Jun 1, 2026
First close after public filing
$303.64
Jun 4, 2026
30-day return after filing
+3.1%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,175 shares @ $298.91
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001178670-26-000048
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$1.15M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. ALNY | Exercise | Jun 1, 2026 | $0 |
| Alnylam Pharmaceuticals, Inc. ALNY | Sale | Jun 1, 2026 | $274.19K |
| Alnylam Pharmaceuticals, Inc. ALNY Current | Sale | Jun 1, 2026 | $351.22K |
| Alnylam Pharmaceuticals, Inc. ALNY | Sale | Jun 1, 2026 | $366.44K |
| Alnylam Pharmaceuticals, Inc. ALNY | Sale | Jun 1, 2026 | $148.86K |
| Alnylam Pharmaceuticals, Inc. ALNY | Sale | Jun 1, 2026 | $5.15K |
| Alnylam Pharmaceuticals, Inc. ALNY | Exercise | Jun 1, 2026 | $0 |